Navigation Links
Arena Pharmaceuticals to Present at Two Upcoming Investor Conferences
Date:3/13/2008

SAN DIEGO, March 13 /PRNewswire-FirstCall/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) announced today that the company is scheduled to provide an overview of the company, including its clinical development and discovery programs, at two upcoming investor conferences:

-- Cowen 28th Annual Health Care Conference

Presentation: Wednesday, March 19, 2008 at 8:45 a.m. Eastern Time (5:45

a.m. Pacific Time) at the Boston Marriott Copley Place in Boston,

Massachusetts

Presenting: Jack Lief, Arena's President and Chief Executive Officer

-- Lehman Brothers Eleventh Annual Global Healthcare Conference

Presentation: Thursday, March 20, 2008 at 10:45 a.m. Eastern Time (7:45

a.m. Pacific Time) at the Loews Miami Beach Hotel in Miami, Florida

Presenting: Robert E. Hoffman, Arena's Vice President, Finance and

Chief Financial Officer

A live audio webcast of each presentation will be available under the investor relations section of Arena's website at http://www.arenapharm.com. A replay of each presentation will be available for 30 days following the event. Please connect to Arena's website several minutes prior to the start of the webcast to ensure adequate time for any software download that may be necessary.

About Arena Pharmaceuticals

Arena is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing oral drugs in four major therapeutic areas: cardiovascular, central nervous system, inflammatory and metabolic diseases. Arena's most advanced drug candidate, lorcaserin, is being investigated in a Phase 3 clinical trial program for the treatment of
'/>"/>

SOURCE Arena Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Arena Pharmaceuticals to Present at the Bear Stearns 20th Annual Healthcare Conference
2. Arena Pharmaceuticals Continues Phase 3 BLOOM Obesity Trial Following Independent Echocardiogaphic Data Safety Monitoring Board Review
3. Arena Pharmaceuticals Continues Phase 3 BLOOM Obesity Trial Following Independent Echocardiographic Data Safety Monitoring Board Review
4. Arena Pharmaceuticals Selected to Join New NASDAQ NeuroInsights Neurotech Index
5. Arena Pharmaceuticals to Present at Two Upcoming Investor Conferences
6. Arena Pharmaceuticals to Report Third Quarter 2007 Financial Results and to Host Conference Call and Webcast on Wednesday, October 17, 2007
7. Arena Pharmaceuticals Announces Third Quarter 2007 Financial Results
8. Arena Pharmaceuticals to Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
9. Arena Pharmaceuticals Appoints Phillip M. Schneider and Randall E. Woods to Board of Directors
10. Arena Pharmaceuticals Initiates Second and Third Pivotal Trials Evaluating Lorcaserin for the Treatment of Obesity
11. Arena Pharmaceuticals Enters Into Strategic Agreements for the Manufacture of Pharmaceutical Material, Including Lorcaserin
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... 2014 The ability for organizations to ... will allow individuals to perform at the highest of ... employers looking to compete in this post–recession era. ... trend, as the sector increasingly focuses on the importance ... will have real results on the organization's development and ...
(Date:8/28/2014)... a Florida State University research team has led to ... emit white light, and convert photon energy directly to ... butterfly. , Biwu Ma, associate professor in the Department ... of Engineering, created the molecule in a lab about ... his creation has many other unique capabilities. , For ...
(Date:8/28/2014)... Diego, CA (PRWEB) August 28, 2014 ... Pipette.com is offering a promotion for Eppendorf ... Pipette.com customers to purchase the highest quality tubes ... Tubes are ideal for customers doing chemical, medical, ... lab technicians who are not regularly able to ...
(Date:8/27/2014)... In 2013, Lawrence Livermore ... National Security LLC (LLNS), was awarded more ... state-of-the-art laser system for the European Union's Extreme ... in the Czech Republic. , When commissioned to ... the " High repetition-rate Advanced Petawatt Laser System ...
Breaking Biology Technology:Klein Hersh International Leads Philadelphia Area Life Science Industry in Company Culture 2Klein Hersh International Leads Philadelphia Area Life Science Industry in Company Culture 3Novel 'butterfly' molecule could build new sensors, photoenergy conversion devices 2Eppendorf Safe Lock Centrifuge Tube Promotion Now Available at Major Pipette Distributor Pipette.com 2Eppendorf Safe Lock Centrifuge Tube Promotion Now Available at Major Pipette Distributor Pipette.com 3LLNL Synchs up with ELI Beamlines on Timing System 2LLNL Synchs up with ELI Beamlines on Timing System 3
... developed a ground-breaking method for testing the quality of ... increase the chances of conception. , Researchers at the ... Physical Sciences Research Council), have created a way of ... quality. Scientists can then consider whether the sperm is ...
... ALTO, Calif., Jan. 21 Cell Biosciences, Inc., ... researchers, today,announced the launch of its first kits ... 3000 Protein Analysis System. The new kits are,optimized ... ERK families, which,play critical roles in cancer cell ...
... NOIDA, India, Jan. 21 Jubilant Organosys Ltd,headquartered ... its subsidiary,Jubilant Biosys Ltd., based in Bangalore, has ... will further enable the process of,high throughput screening, ... launched in the US and Europe initially, allows ...
Cached Biology Technology:New sperm shaker to improve IVF success 2Cell Biosciences Introduces Kits for Oncoprotein Analysis 2Jubilant Biosys Launches Legend NGSS(TM) Advanced Software Solution for High-Throughput Drug Molecule Screening 2
(Date:8/27/2014)... Calif. , Aug. 27, 2014  WaferGen Bio-systems, ... its previously announced underwritten public offering of units of ... per unit for gross proceeds of $20 million, prior ... payable by the Company.  The shares and warrants are ... Each unit sold in the offering consists of ...
(Date:8/27/2014)... , Aug. 27, 2014 Reportlinker.com announces ... in its catalogue: Law Enforcement Biometrics ... http://www.reportlinker.com/p02316674/Law-Enforcement-Biometrics-Market-in-North-America-2014-2018.html About Biometrics Biometrics ... on the basis of their physical or behavioral ... both physiological traits such as fingerprints, face recognition, ...
(Date:8/27/2014)... Learning is easier when it only requires nerve cells ... nerve cells have to generate new patterns, a study ... capacity to learn through recordings of electrical activity of ... the National Institutes of Health. , "We looked into ... hard to think outside the box," said Aaron Batista, ...
Breaking Biology News(10 mins):WaferGen Bio-Systems Announces Successful Completion of Public Offering Raising $20 Million 2WaferGen Bio-Systems Announces Successful Completion of Public Offering Raising $20 Million 3Law Enforcement Biometrics Market in North America 2014-2018 2Law Enforcement Biometrics Market in North America 2014-2018 3Law Enforcement Biometrics Market in North America 2014-2018 4Law Enforcement Biometrics Market in North America 2014-2018 5Scientists plug into a learning brain 2Scientists plug into a learning brain 3
... N.C. , Sept. 17, 2013  GenesisSolutions (An ABS ... will be hosting a complimentary Life Sciences EAM Symposium ... 5, 2013 at The Umstead Hotel in ... of this educational session is to provide participants with ...
... NY (September 17, 2013) The New York Genome ... Cell Foundation (NYSCF) has become an Associate Member, joining ... all working together in new ways to utilize genomic ... "Biologists at the NYSCF working with the genomic ...
... excellent economics teacher, but some would be surprised to learn ... cleaner than the first breath they ever took. In ... improvements in U.S. air quality since 1990 have sparked a ... air pollution. Pope was a member of a large research ...
Cached Biology News:Life Sciences EAM Symposium 2Life Sciences EAM Symposium 3New York Genome Center announces the New York Stem Cell Foundation as an Associate Member 2New York Genome Center announces the New York Stem Cell Foundation as an Associate Member 3Death & disability from air pollution down 35 percent in the US 2
Rabbit polyclonal to 13,14 dihydro 15 keto Prostaglandin E2 ( Abpromise for all tested applications)....
Goat polyclonal to T7 tag (Agarose) Immunogen: Goats were immunized with MASMTGGQQMG (T7) conjugated to KLH.After multiple immunizations in Freund's adjuvant, serum was collected....
Insect Cell Lysis Buffer 50 ml...
Mouse monoclonal [11C9] to Zeralenone ( Abpromise for all tested applications). Antigen: Chemical / Small Molecule conjugated to BSA: Zeralenone...
Biology Products: